79 related articles for article (PubMed ID: 30820592)
1. Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.
Angarita SAK; Truong B; Khoja S; Nitzahn M; Rajbhandari AK; Zhuravka I; Duarte S; Lin MG; Lam AK; Cederbaum SD; Lipshutz GS
Mol Genet Metab; 2018 Jun; 124(2):114-123. PubMed ID: 29724658
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation of the Liver Increases the Transplant Engraftment of Hepatocytes.
Han S; Dicker ML; Lopez-Ichikawa M; Vu NK; Rubinsky B; Chang TT
J Surg Res; 2024 Jan; 293():128-135. PubMed ID: 37738854
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
Weir GC; Ehlers MR; Harris KM; Kanaparthi S; Long A; Phippard D; Weiner LJ; Jepson B; McNamara JG; Koulmanda M; Strom TB;
Pediatr Diabetes; 2018 Aug; 19(5):945-954. PubMed ID: 29473705
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro.
Aldonyte R; Jansson L; Janciauskiene S
BMC Cell Biol; 2004 Mar; 5():11. PubMed ID: 15050036
[TBL] [Abstract][Full Text] [Related]
5. The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.
Hansel MC; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Davila J; Strom SC
Curr Protoc Toxicol; 2014 Nov; 62():14.12.1-23. PubMed ID: 25378242
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the Secretion and Activity of Alpha-1 Antitrypsin in Various Mammalian Cell Types.
Guay KP; Ke H; Gierasch LM; Gershenson A; Hebert DN
Methods Mol Biol; 2024; 2750():143-163. PubMed ID: 38108975
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation.
Shrestha P; Batra L; Tariq Malik M; Tan M; Yolcu ES; Shirwan H
Am J Transplant; 2020 Oct; 20(10):2703-2714. PubMed ID: 32342638
[TBL] [Abstract][Full Text] [Related]
8. ROCK inhibition enhanced hepatocyte liver engraftment by retaining membrane CD59 and attenuating complement activation.
Ma H; Wang C; Liang S; Yu X; Yuan Y; Lv Z; Zhang J; Jin C; Zhu J; Wang C; Sun P; Li W
Mol Ther; 2023 Jun; 31(6):1846-1856. PubMed ID: 36860134
[TBL] [Abstract][Full Text] [Related]
9. Short-term inhalation of isoflurane improves the outcomes of intraportal hepatocyte transplantation.
Nishimaki H; Saitoh Y; Inagaki A; Nakamura Y; Imura T; Fathi I; Yamana H; Ohashi K; Miyagi S; Kamei T; Unno M; Goto M
Sci Rep; 2022 Mar; 12(1):4241. PubMed ID: 35273344
[TBL] [Abstract][Full Text] [Related]
10. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H
Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642
[TBL] [Abstract][Full Text] [Related]
11. Host conditioning and rejection monitoring in hepatocyte transplantation in humans.
Soltys KA; Setoyama K; Tafaleng EN; Soto Gutiérrez A; Fong J; Fukumitsu K; Nishikawa T; Nagaya M; Sada R; Haberman K; Gramignoli R; Dorko K; Tahan V; Dreyzin A; Baskin K; Crowley JJ; Quader MA; Deutsch M; Ashokkumar C; Shneider BL; Squires RH; Ranganathan S; Reyes-Mugica M; Dobrowolski SF; Mazariegos G; Elango R; Stolz DB; Strom SC; Vockley G; Roy-Chowdhury J; Cascalho M; Guha C; Sindhi R; Platt JL; Fox IJ
J Hepatol; 2017 May; 66(5):987-1000. PubMed ID: 28027971
[TBL] [Abstract][Full Text] [Related]
12. Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives.
Lee CA; Dhawan A; Smith RA; Mitry RR; Fitzpatrick E
Cell Transplant; 2016; 25(7):1227-36. PubMed ID: 26996786
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
14. Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator.
Lee C; Dhawan A; Iansante V; Filippi C; Mitry R; Tang J; Walker S; Fernandez DaCosta R; Sinha S; Hughes RD; Koulmanda M; Fitzpatrick E
J Mol Med (Berl); 2019 Apr; 97(4):563-577. PubMed ID: 30820592
[TBL] [Abstract][Full Text] [Related]
15. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
